Amlodipine besylate and folic acid

DRUG2 trials

Sponsors

Shenzhen Ausa Pharmed Co.,Ltd

Conditions

Elevated Plasma Homocysteine (Hcy≥10µmol/L)HypertensionInsufficient Plasma Folate Levels (<12ng/mL)MTHFR 677 CC or CT GenotypeMTHFR 677 TT Genotype

Phase 4

China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

RecruitingNCT04974138

Shenzhen Ausa Pharmed Co.,LtdElevated Plasma Homocysteine (Hcy≥10µmol/L), Hypertension, Insufficient Plasma Folate Levels (<12ng/mL) +1

Start: 2024-08-22End: 2030-06-30Target: 32000Updated: 2025-02-26

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

RecruitingNCT04974151

Shenzhen Ausa Pharmed Co.,LtdHypertension, MTHFR 677 TT Genotype

Start: 2024-08-22End: 2029-06-30Target: 24000Updated: 2025-02-26